Overlapping substrate and inhibitor specificity of human and murine ABCG2

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• ABCG2 (breast cancer resistance protein) is a key transporter involved in xenobiotic efflux.
• Understanding species differences between mouse and human ABCG2 is crucial for drug development and physiological studies.
• Mouse models are frequently used to study ABCG2 function, necessitating comparison with human ABCG2.

Purpose of the Study:

• To compare the substrate and inhibitor specificities of human and mouse ABCG2.
• To validate a new mouse Abcg2-expressing cell line for functional studies.
• To assess the translational relevance of mouse models for human ABCG2 research.

Main Methods:

• Comparative analysis of drug-selected cell lines expressing human or mouse ABCG2.
• Flow cytometry to measure the efflux of fluorescent substrates.
• Characterization of a novel mouse Abcg2-expressing subline.
• Assessment of inhibitor effects on substrate efflux.

Main Results:

• Human and mouse ABCG2 exhibit very similar substrate specificities.
• Purpurin-18 (Pp-18) was identified as a novel substrate for both human and mouse ABCG2.
• Common inhibitors (chrysin, benzoflavone, cyclosporin A) similarly affected Pp-18 efflux in both species.
• The developed mouse Abcg2 subline demonstrated functional efflux and drug resistance.

Conclusions:

• The functional similarities between human and mouse ABCG2 support the use of mouse models in ABCG2 research.
• Findings validate the utility of mouse models for understanding the clinical, pharmacological, and physiological roles of ABCG2.
• The identification of Pp-18 as a specific ABCG2 substrate offers a new tool for studying transporter activity.